Group One Trading
MDGL icon

Group One Trading’s Madrigal Pharmaceuticals MDGL Stock Holding History

Group One Trading’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.2M Buy
72,900
+1,500
+2% +$717K 0.07% 258
2025
Q4 		$41.6M Buy
71,400
+9,700
+16% +$4.95M 0.07% 252
2025
Q3 		$28.3M Sell
61,700
-191,000
-76% -$71.3M 0.05% 353
2025
Q2 		$76.5M Buy
252,700
+168,800
+201% +$50.3M 0.17% 88
2025
Q1 		$27.8M Sell
83,900
-80,900
-49% -$26.6M 0.08% 224
2024
Q4 		$50.9M Buy
164,800
+32,000
+24% +$9M 0.12% 140
2024
Q3 		$28.2M Sell
132,800
-10,900
-8% -$2.79M 0.08% 195
2024
Q2 		$40.3M Sell
143,700
-104,600
-42% -$24.9M 0.16% 94
2024
Q1 		$66.3M Sell
248,300
-39,000
-14% -$9.19M 0.25% 48
2023
Q4 		$66.5M Sell
287,300
-87,000
-23% -$15.2M 0.17% 68
2023
Q3 		$54.7M Sell
374,300
-9,900
-3% -$1.86M 0.18% 61
2023
Q2 		$88.8M Buy
384,200
+303,500
+376% +$82.2M 0.28% 41
2023
Q1 		$19.6M Sell
80,700
-78,500
-49% -$21.4M 0.07% 216
2022
Q4 		$46.2M Buy
159,200
+158,000
+13,167% +$15.5M 0.11% 161
2022
Q3 		$78K Buy
1,200
+700
+140% +$48.6K ﹤0.01% 5014
2022
Q2 		$36K Sell
500
-9,200
-95% -$676K ﹤0.01% 5841
2022
Q1 		$952K Sell
9,700
-5,000
-34% -$422K ﹤0.01% 3126
2021
Q4 		$1.25M Buy
14,700
+13,000
+765% +$1.07M ﹤0.01% 3120
2021
Q3 		$136K Buy
1,700
+1,300
+325% +$112K ﹤0.01% 5587
2021
Q2 		$39K Sell
400
-1,200
-75% -$142K ﹤0.01% 6776
2021
Q1 		$187K Sell
1,600
-1,700
-52% -$198K ﹤0.01% 5095
2020
Q4 		$367K Buy
3,300
+2,000
+154% +$244K ﹤0.01% 3545
2020
Q3 		$154K Buy
1,300
+100
+8% +$10.9K ﹤0.01% 3861
2020
Q2 		$136K Buy
+1,200
New +$118K ﹤0.01% 3674
2019
Q2 		– Sell
-23,000
Closed -$2.88M – 5204
2019
Q1 		$2.88M Sell
23,000
-7,100
-24% -$883K 0.03% 702
2018
Q4 		$3.39M Buy
30,100
+28,100
+1,405% +$4.35M 0.03% 690
2018
Q3 		$428K Buy
+2,000
New +$502K ﹤0.01% 2411
2016
Q1 		– Sell
-1,991
Closed -$25K – 4778
2015
Q4 		$25K Buy
1,991
+51
+3% +$1.4K ﹤0.01% 3802
2015
Q3 		$118K Sell
1,940
-111
-5% -$8.01K ﹤0.01% 2927
2015
Q2 		$160K Buy
2,051
+734
+56% +$61.6K ﹤0.01% 2706
2015
Q1 		$89K Sell
1,317
-52
-4% -$4.46K ﹤0.01% 2974
2014
Q4 		$127K Buy
1,369
+666
+95% +$68.9K ﹤0.01% 2664
2014
Q3 		$74K Sell
703
-2,140
-75% -$298K ﹤0.01% 3250
2014
Q2 		$407K Sell
2,843
-1,868
-40% -$273K 0.01% 1814
2014
Q1 		$711K Buy
4,711
+1,554
+49% +$306K 0.01% 1357
2013
Q4 		$579K Sell
3,157
-1,249
-28% -$229K 0.01% 1560
2013
Q3 		$973K Sell
4,406
-1,605
-27% -$341K 0.02% 1046
2013
Q2 		$1.05M Buy
+6,011
New +$1.57M 0.03% 787

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Group One Trading's MDGL Position: Q1 2025 in Review

Group One Trading sold out of Madrigal Pharmaceuticals (MDGL) in Q1 2025, closing a stake of 100,146 shares — an estimated $32.9M sold.

Group One Trading first reported a position in MDGL in Q2 2013 and held it in 30 quarters. The position peaked at $44.4M in Q4 2023. 321 funds tracked by Wall St. Rank hold MDGL as of Q1 2025.

  • Group One Trading reported no remaining Madrigal Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Group One Trading sold 100,146 Madrigal Pharmaceuticals shares in Q1 2025, an estimated $32.9M.
  • Group One Trading first reported a position in Madrigal Pharmaceuticals in Q2 2013 and held it in 30 quarters.
  • Group One Trading's Madrigal Pharmaceuticals position peaked at $44.4M in Q4 2023.
  • 321 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2025.

Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.